Search research articles
Contact Us
Filters
Showing results (401-410 of 484) with videos related to
Page
of 49
Sort By:
Expert Review of Clinical Immunology
|
December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022
Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
Seminars in Arthritis and Rheumatism
|
October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review
Corrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)
|
June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
Laura Ross, Nancy Maltez, Michael Hughes, et al.
Clinical Trials (London, England)
|
February 26, 2026
Shaping the future of clinical trials through strategic foresight
Sharon Lee, Jeff McIntyre, Tracey Robertson, et al.
Journal of Scleroderma and Related Disorders
|
July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Alain Lescoat, Susan L Murphy, David Roofeh, et al.
Autoimmunity Reviews
|
February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee
Corrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Expert Review of Clinical Immunology
|
March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patients
Ivan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Rheumatology (Oxford, England)
|
October 28, 2017
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
Michael B Arnold, Dinesh Khanna, Christopher P Denton, et al.
Arthritis and Rheumatism
|
April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Rheumatology (Oxford, England)
|
July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis
Hana Sabanovic, John D Pauling, Murray Baron, et al.
Page
of 49
Search research articles
Search
Showing results (401-410 of 484) with videos related to
Sort By:
Page
of 49
Expert Review of Clinical Immunology
|
December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022
Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
Seminars in Arthritis and Rheumatism
|
October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature review
Corrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)
|
June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review
Laura Ross, Nancy Maltez, Michael Hughes, et al.
Clinical Trials (London, England)
|
February 26, 2026
Shaping the future of clinical trials through strategic foresight
Sharon Lee, Jeff McIntyre, Tracey Robertson, et al.
Journal of Scleroderma and Related Disorders
|
July 28, 2021
Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes
Alain Lescoat, Susan L Murphy, David Roofeh, et al.
Autoimmunity Reviews
|
February 25, 2026
Points to consider for reporting digital ulcers in systemic sclerosis interventional studies: An initiative from the world Scleroderma Foundation digital ulcer ad hoc committee
Corrado Campochiaro, Nancy Maltez, Yossra Suliman, et al.
Expert Review of Clinical Immunology
|
March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patients
Ivan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Rheumatology (Oxford, England)
|
October 28, 2017
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
Michael B Arnold, Dinesh Khanna, Christopher P Denton, et al.
Arthritis and Rheumatism
|
April 29, 2008
Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
Peter A Merkel, Nancy P Silliman, Christopher P Denton, et al.
Rheumatology (Oxford, England)
|
July 11, 2025
'Am I doing this right?' Physician perceptions of the global assessment in clinical trials of systemic sclerosis
Hana Sabanovic, John D Pauling, Murray Baron, et al.
Page
of 49